Related Articles
Clinical outcomes and influencing factors of PD‑1/PD‑L1 in hepatocellular carcinoma (Review)
Mechanistic insight of predictive biomarkers for antitumor PD‑1/PD‑L1 blockade: A paradigm shift towards immunome evaluation (Review)
Current progress and prospect of immune checkpoint inhibitors in hepatocellular carcinoma (Review)
Tumor markers for hepatocellular carcinoma (Review)
Progress and prospects of biomarkers in primary liver cancer (Review)